Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab. [PDF]
Yokoyama T +7 more
europepmc +1 more source
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus. [PDF]
Durmus S +6 more
europepmc +1 more source
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus. [PDF]
Radziszewska A +13 more
europepmc +1 more source
Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study. [PDF]
Kalashnikova E +11 more
europepmc +1 more source
A Teenager With Rash and Fever: Juvenile Systemic Lupus Erythematosus or Kawasaki Disease? [PDF]
Saez-de-Ocariz M +6 more
europepmc +1 more source
Physical activity and quality of life of children and adolescents with juvenile idiopathic arthritis, juvenile systemic lupus erythematosus and juvenile dermatomyositis during the COVID-19 pandemic. [PDF]
Soares R +5 more
europepmc +1 more source
Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus. [PDF]
Kiykim E +7 more
europepmc +1 more source
Active juvenile systemic lupus erythematosus is associated with distinct NK cell transcriptional and phenotypic alterations. [PDF]
Radziszewska A +7 more
europepmc +1 more source
Identifying distinct phenotypes of patients with juvenile systemic lupus erythematosus: results from a cluster analysis by the Egyptian college of rheumatology (ECR) study group. [PDF]
Hammam N +21 more
europepmc +1 more source

